Abstract: The purpose of the present study was to compare the therapeutic effects of risedronate (RIS) and alfacalcidol (ALF) on cancellous and cortical bone in ovariectomized
Introduction
Osteoporosis is recognized as a major public health problem. Because estrogen deficiency associated with menopause causes marked bone loss, osteoporosis primarily affects postmenopausal women. The bisphosphonate, risedronate (RIS) and the active vitamin D 3 , alfacalcidol (ALF), have been widely used for postmenopausal osteoporosis in Japan. Several large randomized controlled trials (RCTs) have demonstrated that RIS reduces the incidence of vertebral and hip fractures in postmenopausal osteoporotic women [7, 8, 12] . However, because no large RCTs have been conducted to determine the anti-fracture efficacy of ALF in postmenopausal osteoporotic women, its efficacy in the treatment of postmenopausal osteoporosis remains to be established.
Several preclinical studies have reported on the effects of RIS and ALF against cancellous osteopenia using a rat model of postmenopausal osteoporosis (the preventive effects of RIS and ALF on osteopenia) [6, 15, 20] . RIS suppresses bone resorption and prevents cancellous bone loss in ovariectomized rats [6, 15] . On the other hand, ALF suppresses bone resorption, but maintains or even stimulates bone formation, thereby increasing the bone mineral density (BMD) and improving the mechanical properties of the bone [20] . However, very few studies have reported on the therapeutic effects of RIS or ALF on the bone mass and mechanical properties in ovariectomized osteopenic rats (the therapeutic effects of RIS and ALF on established osteopenia). The purpose of the present study was to compare the therapeutic effects of RIS and ALF on cancellous and cortical bone in ovariectomized osteopenic rats.
Materials and Methods

Treatment of animals
Forty-two female Sprague-Dawley rats, 7 months of age, were purchased from Charles River Japan (Kanagawa, Japan). They were fed a pelleted standard chow diet containing 1.25% calcium and 0.9% phosphorus (CRF-1: Oriental Kobo, Co., Ltd., Tokyo, Japan). The animals were housed under local vivarium conditions (temperature 23.3°C, humidity 55%, and 12 h on/off light cycle), with free access to water. After allowing one week for adaptation to the new environment, the rats were randomized by the stratified weight method into the following six groups: sham-operation + vehicle (Sham, n=5) group, bilateral ovariectomy (OVX, n=5) + vehicle group, OVX + RIS (0.1 mg/kg [n=8], 1.0 mg/kg [n=8], and 2.5 mg/kg [n=8]) groups, and OVX + ALF (0.5 µg/kg, n=8) group. The treatment with vehicle, RIS, or ALF was started 6 weeks after surgery and continued for 6 weeks. Bilateral OVX was performed under general anesthesia induced by intraperitoneal injection of 25-30 mg/kg pentobarbital sodium. Tablet forms of RIS (Actonel, Aventis Pharma, Tokyo, Japan) or ALF (One-alfa, Teijin Pharma, Tokyo, Japan) were pulverized, dissolved in 0.1 ml of sterile saline, and administered orally to the animals daily by gavage deep into the mouth. The doses of RIS and ALF were determined based on the results of previous studies [6, 13, 15, 20] ; the daily dose of ALF (0.5 µg/kg) was 5 times higher than the effective daily dose (0.1 µg/kg) for preventing the loss of the proximal, middle, and distal femoral BMD in OVX rats [20] , while the daily doses of RIS, 0.1 mg/kg, 1.0 mg/kg, and 2.5 mg/kg were within the range of doses previously tested in OVX or hind-limb immobilized rats [6, 13, 15] . The skeletal efficacy of ALF in ovariectomized rats has clearly been established [20] . Because the present study focused on investigating the effect of RIS on established osteopenia after OVX and comparing the skeletal efficacy between RIS and ALF, the highly effective dose of ALF and the low, middle, and high dose of RIS were selected. Only vehicle (0.1 ml of sterile saline) was also administered orally to the animals daily by gavage in the Sham-vehicle and OVXvehicle groups. The body weight of the rats was monitored weekly, and the total duration of the experiment was 12 weeks. The present study was carried out at the laboratory of Hamri Co., Ltd. (Ibaraki, Japan). The animals were maintained according to the National Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals, and the animal experiment protocols were approved by the Laboratory Animal Care Committee of Hamri Co., Ltd. (Ibaraki, Japan).
Preparation of specimens
Urine samples from all the rats were collected over a 24 h period using metabolic cages 6, 9, and 12 weeks after the start of the experiment, and the specimens were stored at -20°C. All the rats were labeled with 25 mg/kg of tetracycline (Sigma Chemical, St. Louis, MO, USA) injected intramuscularly and 8 mg/kg of calcein (Sigma Chemical, St. Louis, MO, USA) injected subcutaneously, 9 days and 3 days, respectively, before sacrifice. The animals were sacrificed 12 weeks after the surgery by exsanguination under anesthesia induced by intraperitoneal injection of 25-30 mg/kg of pentobarbital sodium. Upon sacrifice, serum specimens were collected from all the rats, and the right femur and right tibia were isolated.
The serum samples were stored at -20°C. The urine and serum samples were used for the measurements of biochemical markers as described below. The femurs were stored at -20°C and then used for biomechanical testing as described below. The tibiae were processed for bone histomorphometric analyses. The bones were fixed in cold 40% ethanol overnight, and then cut into three parts using an Isomet saw (Buehler, Lake Bluff, IL, USA). The proximal tibial metaphysis and tibial diaphysis with the fibular junction were stained with Villanueva Osteochrome Bone Stain (Polyscience, Warrington, PA, USA) for 5 days. The specimens were dehydrated sequentially in ascending concentrations of ethanol (70%, 95%, and 100%) and xylene, and then embedded in methyl-methacrylate (EM Science, Gibbstown, NJ, USA) at 4°C according to the method of Erben [5] . Cross-sections of the tibial diaphysis just proximal to the tibio-fibular junction were cut at 40 µm thickness using a diamond wire Histo-Saw machine (Delaware Diamond Knives, Wilmington, DE, USA), and the thickness of each cross-sectional specimen was determined with an Inspectors' Dial Bench Gauge (L.S. Starrett, Athol, MA, USA). Frontal sections of the proximal tibial metaphysis were cut at 8 µm or 4 µm thickness using a microtome (Leica RM2155; Leica Inc., Nussloch, Germany). The 8 µm sections were then transferred onto chromalum-gelatin-coated slides and dried overnight under a press at 42°C. All the sections were coverslipped with Eukitt (Calibrated Instruments, Hawthorne, NY, USA) for the static and dynamic histomorphometric analyses. For tartrate-resistant acid phosphatase (TRAP) histochemistry, the 8-µm sections of the proximal tibial metaphysis were deplasticized with three changes of 2-methoxyethylacetate for 30 min each, two changes of acetone for 5 min each, and sequential changes of ethanol (95%, 70%, and 40%), followed by two changes of deionized water for 5 min each for rehydration. The deplasticized and rehydrated sections (8 µm thickness) were placed in 0.1 M acetate buffer at pH 5.0 for 5 min, and the TRAP reaction was performed using a leukocyte acid phosphatase kit (Sigma Chemical, St. Louis, MO, USA). Sections stained for TRAP were counterstained with Mayer's hematoxylin (1 min) and then air-dried and mounted with a plastic UV mounting medium (Polysciences Inc., Warrington, PA, USA). For Goldner Trichrom staining to count the osteoblast surface, adjacent 4-µm sections of the proximal tibia metaphysis were deplasticized and rehydrated, followed by the procedure of Goldner Trichrom stain and mounting with Eukitt (Calibrated Instruments, Hawthorne, NY, USA).
Urine and serum biochemical analyses
The levels of urinary deoxypyridinoline (DPD) as a bone resorption marker were measured by enzyme-immunoassay (EIA) using a Pyrilinks-D kit (Metra Biosystems Inc., CA, USA). The serum calcium and phosphorus levels were measured by the o-CPC and ammonium molybdate colorimetric methods, respectively, using an autoanalyzer (Dada Behring Model RXL, Bakersfield, CA, USA). The levels of serum osteocalcin (OC) as a bone formation marker were measured by immunoradiometric assay (IRMA) using a Rat Osteocalcin IRMA kit (Immutopics, Inc., CA, USA).
Biomechanical testing
The mechanical properties of the diaphysis of the femur were evaluated by the three-point bending test. Load was applied midway between two supports placed 15 mm apart on the bone. The femur was positioned so that the loading point was at the center of the femoral diaphysis and bending occurred about the medial-lateral axis. The specimens were tested in a saline bath at 37°C. Each specimen was submerged in the saline bath for about 3 min before testing, to allow temperature equilibration. Load-displacement curves were recorded at a crosshead speed of 20 mm/min using a materials-testing machine (MZ500D; Maruto, Co., Ltd., Tokyo, Japan). The parameters analyzed were the maximum load, stiffness, and breaking energy.
Immediately after the three-point bending test of the right femoral diaphysis, the distal metaphysis was isolated over a length of 10 mm from the joint surface of the femoral condyle. The mechanical properties of this segment were then measured by the compression test. Compressive load was applied by the rectangular parallelepiped crosshead (length 2 cm, width 2 cm, and height 1 cm) on the specimens from the lateral to the medial aspect. The specimens were tested in a saline bath at 37°C. Each specimen was submerged in the saline bath for about 3 min before testing, to allow temperature equilibration. Load-displacement curves were recorded at a crosshead speed of 10 mm/min and compression depth of 2.5 mm, using a materials-testing machine (MZ500D; Maruto, Co., Ltd., Tokyo, Japan). The parameters analyzed were the maximum load, stiffness, and breaking energy.
Bone histomorphometry of the tibia
A digitizing morphometry system was used to measure the bone histomorphometric parameters of the tibial specimens. The system consisted of an epifluorescence microscope (Nikon E-400, OsteoMetrics, Atlanta, GA, USA), an Osteomeasure High Resolution Color Subsystem (OsteoMetrics, Atlanta, GA, USA), and a digitizing pad (Numonics 2206; Numonics Corp., Montomerville, PA, USA) coupled to an IBM computer, and a morphometry program (OsteoMetrics, Atlanta, GA, USA). The measured parameters for cancellous bone included the total tissue volume (TV), bone volume (BV), bone surface (BS), eroded surface (ES), single-and double-labeled surfaces (sLS and dLS, respectively), and osteoblast surface (ObS). These data were used to calculate the percent cancellous bone volume (BV/TV), trabecular number (Tb N), trabecular thickness (Tb Th), trabecular separation (Tb Sp), ES/ BS, MS/BS [(sLS/2+dLS)/BS], mineral apposition rate (MAR), bone formation rate (BFR)/BS, BFR/BV, and ObS/BS, in accordance with the standard nomenclature described by Parfitt et al. [16] . In the present study, the region of cancellous bone measured was 1-4 mm distal to the lower margin of the growth plate in the proximal tibia, which consists of secondary spongiosa. Cells showing positive staining for TRAP were counted in the region extending from the distal end of the growth plate to 0.2 mm from the growth plate, and the number of osteoclasts (N.Oc) and the osteoclast surface (OcS) per BS were calculated. The measured parameters for cortical bone were the total tissue area (Tt Ar), cortical bone area (Ct Ar), endocortical ES, periosteal and endocortical BS, sLS, dLS, and the interlabel width. These data were used to calculate the marrow area (Ma Ar), endocortical ES/BS, and periosteal and endocortical MS/BS [(sLS/2+dLS)/BS], MAR, and BFR/BS.
Statistical analysis
All the data were expressed as means and standard deviation (SD). Multiple comparisons of data among the groups were performed by analysis of variance (ANOVA) with Fisher's protected least significant difference (PLSD) test. All statistical analyses were performed using the Stat View J-5.0 program on a Macintosh computer. A significance level of P<0.05 was used for all the comparisons. (Table 1) The body weight at surgery did not differ significantly among the six groups. OVX was associated with an increase in the body weight of the animals. Neither RIS nor ALF affected the body weight of the ovariectomized animals. Table 2) OVX increased the urinary DPD and serum OC levels. RIS (at all the doses) decreased the serum phosphorus levels with the greatest decrease by RIS (2.5 mg/kg), while serum calcium levels were only decreased by RIS (2.5 mg/kg). RIS (1.0 mg/kg and 2.5 mg/kg) prevented the elevation of both the serum OC and urinary DPD levels, however, RIS (0.1 mg/kg) only attenuated the increase of the urinary DPD levels. A greater decrease of the serum OC levels was observed in the RIS (2.5 mg/kg) group than in the RIS (1.0 mg/ kg) group. On the other hand, ALF mildly prevented the elevation of both the markers, without inducing any significant hypercalcemia.
Results
Changes in body weight
Biochemical markers (
Bone histomorphometric analysis of the cancellous bone of the proximal tibial metaphysis (Fig. 1 and Table 3 )
The cancellous BV/TV, Tb N, and Tb Th were decreased, and the Tb Sp was increased, 12 weeks after OVX, as a result of increased bone resorption (ES/BS, N.Oc/BS, OcS/BS) and bone formation (ObS/BS, MS/ BBS, BFR/BS, BFR/BV). RIS (at all the doses) increased the BV/TV, Tb N, and decreased the Tb Sp relative to the values observed in the OVX-Vehicle group, but the values were not restored to those observed in the Sham group. The effects of RIS (1.0 mg/ kg and 2.5 mg/kg) were greater than those of RIS (0.1 mg/kg). The OVX-induced decrease of the Tb Th was entirely prevented by RIS (at all the doses), with the value of this parameter being restored to the value observed in the Sham group. ALF also increased the BV/ TV and Tb N and decreased the Tb Sp relative to the values observed in the OVX-Vehicle group, but the values were not restored to those observed in the Sham group. Furthermore, ALF also increased the Tb Th and the increase of this parameter following ALF treatment was more marked than that following RIS treatment (at all the doses). Thus, the alterations of the structural parameters induced by RIS (at all the doses) were attributable to suppression of the increase of bone resorption (ES/BS) and formation (BFR/BS, BFR/BV), and the alterations of the structural parameters induced by ALF were attributable to suppression of the increase of bone resorption (ES/BS), while bone formation (ObS/ BS, MS/BS, BFR/BS) was maintained. The effect of ALF on cancellous BV/TV was similar to that of RIS (1.0 mg/kg and 2.5 mg/kg).
Bone histomorphometric analysis of the cortical bone of the tibial diaphysis (Fig. 2 and Table 4) OVX did not affect the Tt At or Ct Ar, despite stimulated periosteal bone formation (MS/BS, BFR/BS), but increased the Ma Ar as a result of increased endocortical bone resorption (ES/BS) and, subsequently, increased endocortical bone formation (BFR/BS). RIS (at all the doses) prevented the increase of the Ma Ar, restoring it to the value observed in the Sham group. On the other (Table 5) OVX decreased the maximum load of the femoral distal metaphysis, without any effect on the mechanical properties of the femoral diaphysis. RIS (at all the doses) had no effects on the mechanical properties of the femoral distal metaphysis or diaphysis, whereas ALF prevented the loss of the maximum load and increased the breaking energy of the femoral distal metaphysis, without any effect on the mechanical properties of the femoral diaphysis. 
Biomechanical test of the femur
Discussion
The present study showed the differential effects of RIS and ALF on cancellous and cortical bone in ovariectomized osteopenic rats. The strengths of this study are the detailed bone histomorphometric analyses of cancellous and cortical bone, the measurement of biochemical markers of bone turnover, and the measurement of the mechanical properties of the femoral distal metaphysis. The weaknesses are the ineffectiveness of both treatments in restoring the cancellous BV/TV to the osteopenic skeleton after OVX, despite decreased multiple parameters related to bone remodeling. The two treatments increased the cancellous BV/TV compared with OVX-Vehicle-controls, but could not restore to the values seen in Sham-controls. Because the two treatments were impotent, switching to potent anabolic agents such as parathyroid hormone (PTH) might completely restore the cancellous BV/TV in ovariectomized osteopenic rats.
The effects of OVX on cancellous and cortical bone have already been established, and our results can be comparative with those of a number of previous studies. In particular, we confirmed that OVX resulted in cancellous osteopenia by 6 weeks after surgery in 6-month-old rats, without inducing cortical osteopenia because of the absence of Haversian-based remodeling in rat cortical bone [11] . According to this report, our study animals would also have developed cancellous osteopenia by 6 weeks after the OVX.
Bisphosphonates inhibit osteoclast-mediated bone resorption, and loss of osteoclast function and apoptosis is a consequence of loss of function of one or more important signaling proteins. A nitrogen-containing bisphosphonate like RIS is not metabolized but can inhibit enzymes of the mevalonate pathway, thereby preventing the biosynthesis of isoprenoid compounds that are essential for the post-translational modification of small GTPases [18] . RIS has a potent anti-resorptive effect on the bone.
RIS improved not only the connectivity of trabecular bone, but also its thickness by suppressing bone turnover in ovariectomized osteopenic rats. The effects of RIS (1.0 mg/kg) and RIS (2.5 mg/kg), which were similar, were more marked than those of RIS (0.1 mg/kg). Therefore, 1.0 mg/kg was considered to be the minimum effective dose of RIS in the present study. However, RIS did not completely restore the cancellous BV/TV to the value observed in the Sham group, reflecting its limitation in increasing cancellous bone mass. It is possible that RIS reduced the amount of remodeling space and then increased the cancellous bone mass. The decreases of the serum calcium and phosphorus levels after RIS treatment, with the greatest decreases by RIS (2.5 mg/kg), suggest that RIS treatment resulted in accumulation of minerals in the bone. The effect of RIS on bone metabolism was similar in ovariectomized rats with and without established osteopenia [6, 15] .
The active and hormonal form of vitamin D, 1α, 25-dihydroxyvitamin D 3 , plays a central role in bone and mineral homeostasis through binding to the vitamin D receptor in calcium-related target organs, including the intestine, bone, kidney, and parathyroid gland [1, 17] . One α, 25(OH) 2 D 3 stimulates calcium absorption from the intestine, regulates bone resorption as well as formation, and enhances calcium reabsorption in the distal renal tubules, while it represses parathyroid hormone gene transcription in the parathyroid glands [1, 17] . One α-hydroxyvitamin D 3 (ALF), which is the prodrug of 1α, 25-dihydroxyvitamin D 3 , has been widely used in the treatment of a variety of metabolic bone diseases, such as rickets/osteomalacia, renal osteodystrophy, and osteoporosis [1, 17] . A clinical study showed that ALF reduced bone turnover and prevented vertebral fractures in postmenopausal women with osteoporosis [14] . However, ALF shows a relatively low effectiveness and the risk of developing hypercalciuria/hypercalcemia and urinary stones, resulting in a relatively narrow therapeutic window [4] . An experimental study, which was conducted to investigate the preventive effect of ALF on osteopenia in ovariectomized rats, clearly showed that ALF suppressed bone resorption, but maintained or even stimulated bone formation [20] . ALF improved not only the connectivity of trabecular bone, but also its thickness by suppressing bone turnover but maintaining bone formation in ovariectomized osteopenic rats. These alterations in bone formation and resorption in ovariectomized osteopenic rats were similar to those observed in a previous study that examined the preventive effect of ALF on the cancellous bone loss in ovariectomized rats [20] . The effect of ALF on the cancellous BV/TV was similar to that of RIS (1.0 mg/kg and 2.5 mg/kg). However, the suppression of bone turnover by ALF was milder than that by RIS (at all the doses). Thus, ALF had a milder antiresorptive effect than RIS on cancellous bone in ovariectomized osteopenic rats, and also appeared to have the potential to maintain bone formation, differing in this respect from RIS. The increase in the Tb Th induced by ALF was more marked than that induced by RIS (at all the doses), probably due to maintained bone formation. However, the cancellous BV/TV was not restored to the level observed in the Sham group, reflecting the limitation of ALF at our dose setting in increasing the cancellous bone mass.
OVX decreased the maximum load of the femoral distal metaphysis, associated with a decrease in the cancellous BV/TV. Despite the similar effects of RIS and ALF on the cancellous BV/TV, RIS (at all the doses) had no effects on the mechanical properties of the femoral distal metaphysis, whereas ALF prevented the loss of the maximum load and increased the breaking energy of the femoral distal metaphysis. These results may partly be attributable to the more pronounced effect of ALF than RIS on the Tb Th. The Tb Th may be an important factor in determining the bone strength, as observed in rats treated with vitamin K 2 [9, 10] . Thus, the efficacy of ALF in improving the mechanical properties of the bone in ovariectomized osteopenic rats observed in the present study might be attributable, at least in part, to the marked increase of the Tb Th induced by the drug.
Clinically, it is apparent that RIS is more effective than ALF in increasing the lumbar BMD and reducing the incidence of vertebral fractures in postmenopausal osteoporotic women [3] . Nevertheless, in the present study, ALF induced an increase of the cancellous BV/ TV similar to that of RIS. This discrepancy between the clinical and experimental results may be due to the differential responses of cancellous bone to ALF between ovariectomized osteopenic rats and postmenopausal osteoporotic women (humans). In fact, the potent preventive effect of alfacalcidol on cancellous bone loss after OVX in rats has been confirmed in the previous studies [20] ; thus, ALF might exert greater beneficial effects on rat bones than on human bones.
Increased endocortical bone resorption and periosteal bone formation seem to be similar in ovariectomized osteopenic rats and postmenopausal osteoporotic women [19] . Thus, the pharmacological effects of the drugs on the endocortical bone in ovariectomized osteopenic rats can be exactly translatable into clinically beneficial effects on the endocortical bone in postmenopausal osteoporotic women. ALF, but not RIS, increased the Ct Ar, mainly by decreasing endocortical bone resorption and increasing endocortical bone formation. However, perhaps because this effect was modest, the mechanical properties of the femoral diaphysis were not improved. Also, RIS did not decrease endocortical bone resorption in the present study, probably because osteoclasts on the endocortical surface may be less responsive to bisphosphonates than those on the trabecular surface [2] .
In conclusion, the present study demonstrated that RIS and ALF increased the cancellous bone mass by suppressing bone turnover in ovariectomized osteopenic rats. The effects of both ALF and RIS (at effective doses) were similar on the cancellous bone mass. ALF was associated with maintained or even stimulated bone formation and a marked increase of the trabecular thickness. Also, only ALF increased the cortical bone mass, and prevented the loss of the maximum load of the metaphysis of the femur. Thus, the present study showed the differential effects of RIS and ALF on cancellous and cortical bone in ovariectomized osteopenic rats.
